Your session is about to expire
← Back to Search
COVID-19 Testing Methods for Coronavirus
N/A
Waitlist Available
Led By Jason E Farley, PhD, MPH, NP
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured from testing completion to receipt of results (within 10 days of testing)
Awards & highlights
Study Summary
This trial will test different ways of testing for COVID-19 in 1,386 households in Baltimore City to find the best method.
Who is the study for?
The C-FORWARD trial is for households in Baltimore City with at least one English or Spanish-speaking adult who can consent. Households must have members willing to complete surveys and, if there are children aged 12 or older, they must also assent.Check my eligibility
What is being tested?
This study is testing three COVID-19 testing methods: standard fixed-site testing, mobile van testing within the community, and self-collected home-based tests. The goal is to find out which method works best by randomly assigning 1,386 households to one of these options.See study design
What are the potential side effects?
Since this trial involves non-invasive COVID-19 testing methods rather than medication or vaccines, side effects are minimal but may include discomfort from swab collection or anxiety related to test results.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured from testing completion to receipt of results (within 10 days of testing)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured from testing completion to receipt of results (within 10 days of testing)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Uptake of SARS-CoV-2 testing as assessed by proportion of participants who complete testing
Secondary outcome measures
Receipt of SARS-CoV-2 testing results
Time from SARS CoV-2 testing to receipt of results
Time to completion of SARS CoV-2 testing
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Self-collected testingExperimental Treatment1 Intervention
Self-collected, home-based testing
Group II: Fixed site SOC testingExperimental Treatment1 Intervention
Fixed site Standard of Care (SOC) testing
Group III: Community-based testingExperimental Treatment1 Intervention
Community-based, mobile van testing
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,267 Previous Clinical Trials
14,834,607 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,272 Previous Clinical Trials
5,482,596 Total Patients Enrolled
Jason E Farley, PhD, MPH, NPPrincipal InvestigatorJohns Hopkins University School of Nursing
2 Previous Clinical Trials
3,677 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a child aged 12 or older and agree to participate.The person's primary residence is in the household that is being sampled.Someone in my home can mentally handle completing a survey.Someone in my home over 18 speaks English or Spanish.Someone in my household over 18 speaks English or Spanish.I am not mentally able to complete a survey.I am 12 years or older and agree to participate.and Baltimore County to purchase a single-family homeRequirements for families to participate in the study.for all studies
At least one person in the household agrees to all studies that are conducted in their home.Requirements for people who can participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Fixed site SOC testing
- Group 2: Community-based testing
- Group 3: Self-collected testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment still open to participants?
"It appears that the research posted on clinicaltrials.gov is no longer recruiting patients, as it was first listed in February 8th 2021 but last updated December 7th 2021. Nevertheless, there are still 91 other studies open for recruitment at this time."
Answered by AI
What is the anticipated result of this experiment?
"This medical research has the primary objective of determining uptake rates regarding SARS-CoV-2 testing within a 30 day period post randomization. Secondary endpoints include: time to completion of testing, amount of time needed for results from tests to be received by participants, and uptake rate concerning SARS CoV-2 testing in relation to those randomly chosen for this study."
Answered by AI
Who else is applying?
What state do they live in?
Maryland
How old are they?
18 - 65
What site did they apply to?
2212 McElderry Street
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger